- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: N.159
- Chain C: S.213, P.215, R.216
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.216, C:R.216, C:R.216
NAG-NAG.11: 4 residues within 4Å:- Chain C: N.159
- Chain E: S.213, P.215, R.216
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:R.216, E:R.216, E:R.216
NAG-NAG.20: 4 residues within 4Å:- Chain A: S.213, P.215, R.216
- Chain E: N.159
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.216, A:R.216, A:R.216
- 3 x NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-GAL-SIA.3: 16 residues within 4Å:- Chain A: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, H.177, N.183, D.184, F.187, P.188, R.216, N.219, I.220, S.222
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.183, A:R.216, A:S.131, A:N.219, A:T.129, A:S.131, A:H.177, A:S.222
- Hydrophobic interactions: A:W.147, A:T.149
NAG-GAL-SIA.12: 16 residues within 4Å:- Chain C: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, H.177, N.183, D.184, F.187, P.188, R.216, N.219, I.220, S.222
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:N.183, C:R.216, C:S.131, C:N.219, C:T.129, C:S.131, C:H.177, C:S.222
- Hydrophobic interactions: C:W.147, C:T.149
NAG-GAL-SIA.21: 16 residues within 4Å:- Chain E: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, H.177, N.183, D.184, F.187, P.188, R.216, N.219, I.220, S.222
6 PLIP interactions:6 interactions with chain E- Hydrogen bonds: E:N.183, E:R.216, E:S.131, E:N.219, E:T.129, E:S.131, E:H.177, E:S.222
- Hydrophobic interactions: E:W.147, E:T.149
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 3 residues within 4Å:- Chain A: N.16, T.18, T.31
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: E.56, N.57, Y.88
Ligand excluded by PLIPNAG.6: 4 residues within 4Å:- Chain A: S.39, N.279, V.291, N.292
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain A: Q.126, N.127
Ligand excluded by PLIPNAG.8: 7 residues within 4Å:- Chain A: A.157, L.158, R.195, N.240, S.241, T.242
- Chain C: I.211
Ligand excluded by PLIPNAG.9: 5 residues within 4Å:- Chain B: A.147, G.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain C: N.16, T.18, T.31
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain C: E.56, N.57, Y.88
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain C: S.39, N.279, V.291, N.292
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain C: Q.126, N.127
Ligand excluded by PLIPNAG.17: 7 residues within 4Å:- Chain C: A.157, L.158, R.195, N.240, S.241, T.242
- Chain E: I.211
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain D: A.147, G.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain E: N.16, T.18, T.31
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain E: E.56, N.57, Y.88
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain E: S.39, N.279, V.291, N.292
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain E: Q.126, N.127
Ligand excluded by PLIPNAG.26: 7 residues within 4Å:- Chain A: I.211
- Chain E: A.157, L.158, R.195, N.240, S.241, T.242
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain F: A.147, G.150, S.151, N.154, T.156
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B